Healthcare & Life Sciences
Pulmocide
United Kingdompulmocide.com
Pulmocide is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series C+, 2 tracked investors.
activeseries-c-plus
series-c-plus
Stage
2
Investors
About Pulmocide
Pulmocide is a company headquartered in the United Kingdom. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Pulmocide is a biopharmaceutical company developing inhaled therapies for serious respiratory diseases, primarily focusing on treating invasive pulmonary aspergillosis with its lead compound opelconazole, which is currently in Phase 3 clinical trials.
Explore Pulmocide's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.